NIBEC Company Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
87
- Stock Symbol
-
138610
- Share Price
-
$12.72
- (As of Friday Closing)
NIBEC Company General Information
Description
NIBEC Co Ltd is a South Korea based biotechnology company. It manufactures and markets medicines for mouth, teeth health and tissue recovery. The company's main products are teeth whitening products, materials related to a dental implant, Regenomer, Equimatrix-collagen, OssGen-X 15. It is also involved in cosmetic production and sales.
Contact Information
Website
www.nibec.co.krCorporate Office
- Iwol electricity-electronic Agro-industrial Complex
- 116 Bamdi-gil, Iwol-myeon
- Jincheon-gun, Chungcheongbuk 365-824
- South Korea
Corporate Office
- Iwol electricity-electronic Agro-industrial Complex
- 116 Bamdi-gil, Iwol-myeon
- Jincheon-gun, Chungcheongbuk 365-824
- South Korea
NIBEC Company Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$12.72 | $12.44 | $10.90 - $19.61 | $131M | 10.3M | 157K | -$0.36 |
NIBEC Company Financials Summary
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 131,480 | 165,700 | 144,066 | 239,710 |
Revenue | 14,539 | 12,011 | 16,771 | 11,896 |
EBITDA | (1,020) | (182) | 675 | (1,156) |
Net Income | (3,628) | (4,806) | (2,914) | (5,011) |
Total Assets | 48,407 | 51,838 | 56,210 | 44,770 |
Total Debt | 15,907 | 17,331 | 17,426 | 13,429 |
NIBEC Company Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
NIBEC Company Patents
NIBEC Company Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-2024536278-A | Blood-brain barrier permeation peptides and their uses | Pending | 01-Oct-2021 | ||
EP-4410821-A1 | Peptide for penetrating blood-brain barrier and use thereof | Pending | 01-Oct-2021 | ||
EP-4353268-A1 | Nanoparticle comprising peptide-lipid conjugate for delivering oligonucleotide into target cell and pharmaceutical composition comprising same | Pending | 11-Jun-2021 | ||
EP-4353736-A1 | Bio protac protein having intracellular delivery function, and pharmaceutical composition comprising same | Pending | 11-Jun-2021 | ||
US-20240269302-A1 | Nanoparticle comprising peptide-lipid conjugate for delivering oligonucleotide into target cell and pharmaceutical composition comprising same | Pending | 11-Jun-2021 | A61K47/6455 |
NIBEC Company Executive Team (1)
Name | Title | Board Seat |
---|---|---|
Chong-Pyoung Chung Ph.D | Chief Executive Officer |
NIBEC Company Signals
NIBEC Company FAQs
-
When was NIBEC Company founded?
NIBEC Company was founded in 2004.
-
Who is the CEO of NIBEC Company?
Chong-Pyoung Chung Ph.D is the CEO of NIBEC Company.
-
Where is NIBEC Company headquartered?
NIBEC Company is headquartered in Jincheon-gun, South Korea.
-
What is the size of NIBEC Company?
NIBEC Company has 87 total employees.
-
What industry is NIBEC Company in?
NIBEC Company’s primary industry is Diagnostic Equipment.
-
Is NIBEC Company a private or public company?
NIBEC Company is a Public company.
-
What is NIBEC Company’s stock symbol?
The ticker symbol for NIBEC Company is 138610.
-
What is the current stock price of NIBEC Company?
As of 04-Oct-2024 the stock price of NIBEC Company is $12.72.
-
What is the current market cap of NIBEC Company?
The current market capitalization of NIBEC Company is $131M.
-
What is NIBEC Company’s current revenue?
The trailing twelve month revenue for NIBEC Company is $14.5M.
-
What is NIBEC Company’s annual earnings per share (EPS)?
NIBEC Company’s EPS for 12 months was -$0.36.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »